Nav: Home

Opportunistic cancer cells 'slip through the gaps' to spread through blood vessels

May 02, 2019

Cancer cells may rely on opportunism, as well as chemical signalling, to spread through the body, according to new findings by mathematicians at the University of Birmingham.

Cancer spreads by sending cells out from the primary tumour to travel through the vascular or lymphatic system to colonise other organs in a process called metastasis. During this process the cancer cells need to cross layers of endothelial cell - the cells that line blood or lymphatic vessels.

It has been thought that the cancer cells chemically signal to the endothelial cells making them open up gaps through which the cancer can migrate, but a team of researchers in Birmingham have suggested an alternative, or complementary, process may also be at work.

Working with partners at the Massachusetts Institute of Technology, the University of Zaragoza, and others, the team built a detailed mathematical model of the endothelial cells' behaviour to show how and where openings in the endothelial layer appear, and how long they remain open for.

Their results, published in PLOS Computational Biology, showed how the physical forces within the cells' structure continually push and pull the cells in different directions, sometimes causing the bonds between them to rupture, leaving temporary gaps.

Researchers then tested this model on cell cultures of endothelial monolayers with cancer cells, and observed how the cancer cells were able to capitalise on this endothelial movement and migrate through the gaps.

"The gaps in the endothelium open and close spontaneously - whether cancer cells are present or not," explains lead researcher, Dr Fabian Spill, Lecturer in Applied Mathematics at the University of Birmingham.

"They are caused by an interplay between mechanics and chemistry exerting different forces on the cells. Much work has already been done to characterise the chemistry of the endothelium - our work complements this research, focusing on the mechanical forces at work in these processes."

Interestingly, the researchers also found that openings were most likely to appear at the junctions of three or more cells, as opposed to two-cell borders. Cancer cells that had landed on borders between two cells were able to migrate towards these tricellular junctions, where they leaked through. This indicates that the cancer cells are able not only to signal to the endothelium to chemically open new gaps, they can also employ an opportunistic wait-and-see approach. This enables them to take advantage of the spontaneous formation of gaps in the endothelium.

In this study, the team focused on the vascular system. Future work will examine the lymphatic system or different types of endothelial cells, and will also focus in more detail on other contributing factors to endothelial gap dynamics, such as blood flow and the 3D structure of blood vessels, all of which will affect the ability of cancer cells to transmigrate.
-end-
Notes for editors:

* Spill et al (2019. "Balance of Mechanical Forces Drives Endothelial Gap Formation and May Facilitate Cancer and Immune-Cell Extravasation". PLOS Computational Biology. https://journals.plos.org/ploscompbiol/article?id=10.1371/journal.pcbi.1006395

* The University of Birmingham is ranked amongst the world's top 100 institutions, its work brings people from across the world to Birmingham, including researchers and teachers and more than 6,500 international students from over 150 countries.

University of Birmingham

Related Cancer Articles:

Radiotherapy for invasive breast cancer increases the risk of second primary lung cancer
East Asian female breast cancer patients receiving radiotherapy have a higher risk of developing second primary lung cancer.
Cancer genomics continued: Triple negative breast cancer and cancer immunotherapy
Continuing PLOS Medicine's special issue on cancer genomics, Christos Hatzis of Yale University, New Haven, Conn., USA and colleagues describe a new subtype of triple negative breast cancer that may be more amenable to treatment than other cases of this difficult-to-treat disease.
Metabolite that promotes cancer cell transformation and colorectal cancer spread identified
Osaka University researchers revealed that the metabolite D-2-hydroxyglurate (D-2HG) promotes epithelial-mesenchymal transition of colorectal cancer cells, leading them to develop features of lower adherence to neighboring cells, increased invasiveness, and greater likelihood of metastatic spread.
UH Cancer Center researcher finds new driver of an aggressive form of brain cancer
University of Hawai'i Cancer Center researchers have identified an essential driver of tumor cell invasion in glioblastoma, the most aggressive form of brain cancer that can occur at any age.
UH Cancer Center researchers develop algorithm to find precise cancer treatments
University of Hawai'i Cancer Center researchers developed a computational algorithm to analyze 'Big Data' obtained from tumor samples to better understand and treat cancer.
New analytical technology to quantify anti-cancer drugs inside cancer cells
University of Oklahoma researchers will apply a new analytical technology that could ultimately provide a powerful tool for improved treatment of cancer patients in Oklahoma and beyond.
Radiotherapy for lung cancer patients is linked to increased risk of non-cancer deaths
Researchers have found that treating patients who have early stage non-small cell lung cancer with a type of radiotherapy called stereotactic body radiation therapy is associated with a small but increased risk of death from causes other than cancer.
Cancer expert says public health and prevention measures are key to defeating cancer
Is investment in research to develop new treatments the best approach to controlling cancer?
UI Cancer Center, Governors State to address cancer disparities in south suburbs
The University of Illinois Cancer Center and Governors State University have received a joint four-year, $1.5 million grant from the National Cancer Institute to help both institutions conduct community-based research to reduce cancer-related health disparities in Chicago's south suburbs.
Leading cancer research organizations to host international cancer immunotherapy conference
The Cancer Research Institute, the Association for Cancer Immunotherapy, the European Academy of Tumor Immunology, and the American Association for Cancer Research will join forces to sponsor the first International Cancer Immunotherapy Conference at the Sheraton New York Times Square Hotel in New York, Sept.

Related Cancer Reading:

Best Science Podcasts 2019

We have hand picked the best science podcasts for 2019. Sit back and enjoy new science podcasts updated daily from your favorite science news services and scientists.
Now Playing: TED Radio Hour

Digital Manipulation
Technology has reshaped our lives in amazing ways. But at what cost? This hour, TED speakers reveal how what we see, read, believe — even how we vote — can be manipulated by the technology we use. Guests include journalist Carole Cadwalladr, consumer advocate Finn Myrstad, writer and marketing professor Scott Galloway, behavioral designer Nir Eyal, and computer graphics researcher Doug Roble.
Now Playing: Science for the People

#530 Why Aren't We Dead Yet?
We only notice our immune systems when they aren't working properly, or when they're under attack. How does our immune system understand what bits of us are us, and what bits are invading germs and viruses? How different are human immune systems from the immune systems of other creatures? And is the immune system so often the target of sketchy medical advice? Those questions and more, this week in our conversation with author Idan Ben-Barak about his book "Why Aren't We Dead Yet?: The Survivor’s Guide to the Immune System".